Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Role of ABUS as an Alternative to Breast MRI in Assessing Response to Neoadjuvant Chemotherapy

NCT04468867 is registered in ClinicalTrials.gov with The Leeds Teaching Hospitals NHS Trust as lead sponsor.

NCT NCT04468867
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04468867 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Role of ABUS as an Alternative to Breast MRI in Assessing Response to Neoadjuvant Chemotherapy
Lead sponsor
The Leeds Teaching Hospitals NHS Trust
Phase
Not applicable
Overall status
Unknown status
Start date
August 22, 2019
Completion date
June 30, 2022
Enrollment
100 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

breast cancer